About Us
Metropolis Healthcare Limited is one of leading and renowned Indian diagnostics companies. The Company owns a chain of diagnostic centres across Africa, India, South Asia, and the Middle East. Over the years, Metropolis has carved a niche for itself.
The Company enjoys a loyal customer base, reflecting its strength as a brand offering superior diagnostic tests and services.
With its widespread operational network, Metropolis offers a comprehensive range of clinical laboratory tests and profiles. These tests and profiles are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.
Metropolis plays a pivotal role in raising the bar of diagnostic accuracy, technological equipment, customer experience and research-driven empathetic service in the industry.
The Company’s broad spectrum of services offer around 3,487 clinical laboratory tests and 530 profiles. Various test combinations, specific to a disease or disorder and wellness profiles used for health and fitness screening form a part of the Company’s service profile.
Metropolis has invested in a variety of specialized tests and also adopted several advanced tests and technologies introduced in the global market. One of the prime reasons behind the Company’s leading position in the diagnostics industry is its track record of introducing specialized tests.
Chairman’s Message
Putting our patients first: Delivering reliable pathology
reports
It gives me immense satisfaction to pen down this message as the Chairman of Metropolis
Healthcare Ltd. It has been a long and humbling journey for me personally to see
Metropolis grow as a reputed and trusted pathology brand all across India and markets
in Africa. I started out with a single minded focus on putting our patients’ first and
a relentless pursuit in delivering accurate results and quality reports.
Our promise to the patient is very simple; reliable pathology reports and for that we walk the extra mile for recheck and reflex at no additional cost to our patients.
Working in tandem with doctors because pathology
matters
More than 70% of medical decisions today are based on diagnostic reports. My team of
doctors is constantly in touch with clinicians, work in tandem and help them diagnose
and make treatment decisions for their patients. Be it a simple blood sugar test or a
complicated molecular genetic test, we have built in all the capabilities to deliver
the absolute best.
Quality: A way of functioning at Metropolis
Metropolis has a dedicated quality assurance team that works on accreditations for our
various centers. Our Global Reference Laboratory in Mumbai is accredited by CAP
(College of American Pathologists), a reputed global accreditation board and NABL
(National Accreditation Board for Testing & Calibration Laboratories). To give a
perspective to the benefit of our shareholders, our CAP Proficiency Testing Scores are
above 98% indicating consistently good proficiency.
Metropolis is the only private laboratory to have in-house developed and NABL accredited EQAS program. This program is used to monitor analytical quality of our group labs and 115 group labs is covered currently and is ready for commercial launch for customers.
Warm regards,Dr Sushil ShahFounder & Chairman
Chairman’s Message
Dr Sushil Shah
Chairman and Executive Director
Metropolis has always been at the forefront in bringing new tests and technologies to the people. our test menu comprised of 3,487 clinical laboratory tests and over 530 test profiles.
Ms Ameera Shah
Managing Director
As one of the country’s leading diagnostic companies, MHL continues building and nurturing its talent. Several employee training and development initiatives are often undertaken. This helps incorporate integrity as a core ingredient of the Company’s work culture.
MD’s Message
To begin with, I would like to bring your attention to an Indicator that I have been passionate and relentless about. I am happy to share with you that in FY19, our Net Promoter Score has been on average at 85, which means that 85% of our customers are willing to recommend Metropolis to their family and network. Our Chairman in his note has emphasized on Metropolis’ core vision of putting the patients first and our customer loyalty score is an outcome of this vision.
Moving on to our performance review, we continue to maintain our position in the leaders’ quadrant and are ranked amongst the Top 2 companies in the fast growing Indian diagnostic industry.
Going closer to the patient
FY19 has ended on a positive note for us as the company delivered faster than industry
growth. We are positive on the short and medium term growth for Metropolis owing to
fast paced network expansion, relentless execution, strong brand and customer first
philosophy. We are happy to report a 15.5% growth in number of patient visits with
increase in revenue per patient (2.1%) and revenue per test (11.2%), which are better
than current industry standards.
Bolstering our growth in the wellness space
Our wellness initiative ‘TruHealth’ was launched across 36 cities and we are confident
that this will help us bolster our position in the fast growing wellness segment. It is
heartening to see a positive trend of customers choosing to safeguard their health by
undergoing preventive screening and diagnose conditions before they turn in to
complications.
The Metropolis Family
Our people are at the core of everything we do. Our highly experienced leadership team
leads day to day business and operations. Metropolis’ strong scientific and technical
team of over 2000 members is led by a team of 200 doctors and pathologists. Our
phlebotomists and home service technicians are best in class, highly skilled and
trained to collect samples in a single prick and are efficient in drawing samples from
infants, small children and the elderly. We will make continuous efforts to progress on
diversity and inclusion as we move forward.
Yours truly,Ameera ShahManaging Director